NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/31/2025
Back to search
Official data from USPTO
CASI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
04/01/2025
Trademark type
Word
Nice classes
42
Filing date
04/25/2018
Registration date
05/14/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2025
Last transaction
04/01/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/16/2014
First use in commerce
06/16/2014
Drawing code
4
Owner type
03
Owner location
Rockville, MD
Examiner
SMITH, CYNTHIA
Current location
Historical data usage
Holders and representatives
Holders
CASI PHARMACEUTICALS, INC.
Representatives
Stacey J. Watson MARKERY LAW LLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceuticalbiological and biotechnological products; medical research and product development services in the field of treatments for cancercardiovascularmetabolicinflammatorynervous systemanti-infectivedermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific researchconducting clinical trials for others; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research; Technical research in the field of pharmaceutical studies
Publications
History of USPTO decisions and trademark events.
22 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/31/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/31/2025
E815
TEAS SECTION 8 & 15 RECEIVED
12/12/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/14/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
05/14/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/26/2019
PUBO
PUBLISHED FOR OPPOSITION
02/26/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/06/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/16/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/16/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/16/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/16/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/16/2018
GNRT
NON-FINAL ACTION E-MAILED
08/16/2018
CNRT
NON-FINAL ACTION WRITTEN
08/16/2018
DOCK
ASSIGNED TO EXAMINER
08/16/2018
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/09/2018
ALIE
ASSIGNED TO LIE
05/06/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/04/2018
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
05/01/2018
NWAP
NEW APPLICATION ENTERED
04/28/2018
Continuous trademark protection
Get notified about every new filing that threatens CASI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.